A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors

Conditions:   Solid Tumor;   Non Small Cell Lung Cancer;   Squamous Cell Carcinoma of the Head and Neck;   Urothelial Carcinoma;   Brain Metastasis
Interventions:   Drug: LY3381916;   Drug: LY3300054
Sponsor:   Eli Lilly and Company
Not yet recruiting

http://ift.tt/2iqyRGF